# Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behet disease.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/infliximab-for-the-treatment-of-posterior-uveitis-with-retinal/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Fabrizio Giansanti,M.L. Barbera,Gianni Virgili,B. Pieri,Lorenzo Emmi,Ugo Menchini |
| Citations | 54 |
| DOI | 10.5301/ejo.2008.5480 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1914606342 |
| PMID | 15506610 |
| Type | article |
| Year | 2004 |

## Paper authors

- [Fabrizio Giansanti](https://scholariq.org/researchers/fabrizio-giansanti/)

## Paper journal

- [PubMed](https://scholariq.org/journals/pubmed/)

## Paper primary topic

- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)

## Paper topics

- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)
- [Leptospirosis research and findings](https://scholariq.org/topics/leptospirosis-research-and-findings/)
- [Histiocytic Disorders and Treatments](https://scholariq.org/topics/histiocytic-disorders-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.